{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:07:25Z","timestamp":1794492445827,"version":"4.9.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS097511-01"],"award-info":[{"award-number":["R01 NS097511-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32HD007414-25"],"award-info":[{"award-number":["5T32HD007414-25"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007857","name":"Intellectual and Developmental Disabilities Research Center","doi-asserted-by":"publisher","award":["US4HD079123"],"award-info":[{"award-number":["US4HD079123"]}],"id":[{"id":"10.13039\/100007857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurodevelop Disord"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The mitochondrial aminoacyl-tRNA synthetase proteins (mt-aaRSs) are a group of nuclear-encoded enzymes that facilitate conjugation of each of the 20 amino acids to its cognate tRNA molecule. Mitochondrial diseases are a large, clinically heterogeneous group of disorders with diverse etiologies, ages of onset, and involved organ systems. Diseases related to mt-aaRS mutations are associated with specific syndromes that affect the central nervous system and produce highly characteristic MRI patterns, prototypically the <jats:italic>DARS2<\/jats:italic>, <jats:italic>EARS<\/jats:italic>, and <jats:italic>AARS2<\/jats:italic> leukodystrophies, which are caused by mutations in mitochondrial aspartyl-tRNA synthetase, mitochondria glutamate tRNA synthetase, and mitochondrial alanyl-tRNA synthetase, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Body<\/jats:title>\n                <jats:p>The disease patterns emerging for these leukodystrophies are distinct in terms of the age of onset, nature of disease progression, and predominance of involved white matter tracts. In <jats:italic>DARS2<\/jats:italic> and <jats:italic>EARS2<\/jats:italic> disorders, earlier disease onset is typically correlated with more significant brain abnormalities, rapid neurological decline, and greater disability. In <jats:italic>AARS2<\/jats:italic> leukodystrophy cases reported thus far, there is nearly invariable progression to severe disability and atrophy of involved brain regions, often within a decade. Although most mutations are compound heterozygous inherited in an autosomal recessive fashion, homozygous variants are found in each disorder and demonstrate high phenotypic variability. Affected siblings manifest disease on a wide spectrum.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The syndromic nature and selective vulnerability of white matter tracts in these disorders suggests there may be a shared mechanism of mitochondrial dysfunction to target for study. There is evidence that the clinical variability and white matter tract specificity of each mt-aaRS leukodystrophy depend on both canonical and non-canonical effects of the mutations on the process of mitochondrial translation. Furthermore, different sensitivities to the mt-aaRS mutations have been observed based on cell type. Most mutations result in at least partial retention of mt-aaRS enzyme function with varied effects on the mitochondrial respiratory chain complexes. In <jats:italic>EARS2<\/jats:italic> and <jats:italic>AARS2<\/jats:italic> cells, this appears to result in cumulative impairment of respiration. Mt-aaRS mutations may also affect alternative biochemical pathways such as the integrated stress response, a homeostatic program in eukaryotic cells that typically confers cytoprotection, but can lead to cell death when abnormally activated in response to pathologic states. Systematic review of this group of disorders and further exploration of disease mechanisms in disease models and neural cells are warranted.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s11689-019-9292-y","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T01:02:20Z","timestamp":1576458140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Mitochondrial aminoacyl-tRNA synthetase disorders: an emerging group of developmental disorders of myelination"],"prefix":"10.1186","volume":"11","author":[{"given":"Amena Smith","family":"Fine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina L.","family":"Nemeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam L.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Fatemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,16]]},"reference":[{"issue":"3","key":"9292_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1042\/EBC20170103","volume":"62","author":"V Boczonadi","year":"2018","unstructured":"Boczonadi V, Ricci G, Horvath R. Mitochondrial DNA transcription and translation: clinical syndromes. Essays Biochem. 2018;62(3):321\u201340 Epub 2018\/07\/08.","journal-title":"Essays Biochem."},{"key":"9292_CR2","doi-asserted-by":"publisher","first-page":"16080","DOI":"10.1038\/nrdp.2016.80","volume":"2","author":"GS Gorman","year":"2016","unstructured":"Gorman GS, Chinnery PF, DiMauro S, Hirano M, Koga Y, McFarland R, et al. Mitochondrial diseases. Nat Rev Dis Primers. 2016;2:16080 Epub 2016\/10\/25.","journal-title":"Nat Rev Dis Primers."},{"issue":"4-5","key":"9292_CR3","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/15476286.2017.1330245","volume":"15","author":"J Ognjenovic","year":"2018","unstructured":"Ognjenovic J, Simonovic M. Human aminoacyl-tRNA synthetases in diseases of the nervous system. RNA biology. 2018;15(4-5):623\u201334 Epub 2017\/05\/24.","journal-title":"RNA biology."},{"issue":"R2","key":"9292_CR4","doi-asserted-by":"publisher","first-page":"R114","DOI":"10.1093\/hmg\/ddx231","volume":"26","author":"R Meyer-Schuman","year":"2017","unstructured":"Meyer-Schuman R, Antonellis A. Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease. Hum Mol Genet. 2017;26(R2):R114\u2013R27 Epub 2017\/06\/22.","journal-title":"Hum Mol Genet."},{"issue":"8","key":"9292_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.molmed.2017.06.002","volume":"23","author":"M Sissler","year":"2017","unstructured":"Sissler M, Gonzalez-Serrano LE, Westhof E. Recent advances in mitochondrial aminoacyl-tRNA synthetases and disease. Trends in molecular medicine. 2017;23(8):693\u2013708 Epub 2017\/07\/19.","journal-title":"Trends in molecular medicine."},{"issue":"4","key":"9292_CR6","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/ng2013","volume":"39","author":"GC Scheper","year":"2007","unstructured":"Scheper GC, van der Klok T, van Andel RJ, van Berkel CG, Sissler M, Smet J, et al. Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nature genetics. 2007;39(4):534\u20139 Epub 2007\/03\/27.","journal-title":"Nature genetics."},{"issue":"10","key":"9292_CR7","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/jmg.2011.090282","volume":"48","author":"M Synofzik","year":"2011","unstructured":"Synofzik M, Schicks J, Lindig T, Biskup S, Schmidt T, Hansel J, et al. Acetazolamide-responsive exercise-induced episodic ataxia associated with a novel homozygous DARS2 mutation. Journal of medical genetics. 2011;48(10):713\u20135 Epub 2011\/07\/14.","journal-title":"Journal of medical genetics."},{"issue":"9","key":"9292_CR8","first-page":"16","volume":"109","author":"SV Mikhailova","year":"2009","unstructured":"Mikhailova SV, Zakharova E, Banin AV, Demushkina AA, Petrukhin AS. Clinical and molecular genetic diagnosis of leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation in children. Zhurnal nevrologii i psikhiatrii imeni SS Korsakova. 2009;109(9):16\u201322 Epub 2009\/09\/23.","journal-title":"Zhurnal nevrologii i psikhiatrii imeni SS Korsakova."},{"issue":"8","key":"9292_CR9","first-page":"1180","volume":"34","author":"JG Xu","year":"2011","unstructured":"Xu JG, Zhang JH, Chen JW. Study on the change of the content of cantharidin in Mylabris befere and after biortransfermation. Zhong Yao Cai. 2011;34(8):1180\u20132 Epub 2012\/01\/12.","journal-title":"Zhong Yao Cai"},{"issue":"7","key":"9292_CR10","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1177\/0883073816630087","volume":"31","author":"BD Taskin","year":"2016","unstructured":"Taskin BD, Karalok ZS, Gurkas E, Aydin K, Aydogmus U, Ceylaner S, et al. Early-onset mild type leukoencephalopathy caused by a homozygous EARS2 mutation. Journal of child neurology. 2016;31(7):938\u201341 Epub 2016\/02\/20.","journal-title":"Journal of child neurology."},{"issue":"10","key":"9292_CR11","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/humu.23277","volume":"38","author":"L Moulinier","year":"2017","unstructured":"Moulinier L, Ripp R, Castillo G, Poch O, Sissler M. MiSynPat: an integrated knowledge base linking clinical, genetic, and structural data for disease-causing mutations in human mitochondrial aminoacyl-tRNA synthetases. Hum Mutat. 2017;38(10):1316\u201324 Epub 2017\/06\/14.","journal-title":"Hum Mutat."},{"issue":"Database issue","key":"9292_CR12","doi-asserted-by":"publisher","first-page":"D611","DOI":"10.1093\/nar\/gki079","volume":"33","author":"MC Brandon","year":"2005","unstructured":"Brandon MC, Lott MT, Nguyen KC, Spolim S, Navathe SB, Baldi P, et al. MITOMAP: a human mitochondrial genome database--2004 update. Nucleic acids research. 2005;33(Database issue):D611\u20133 Epub 2004\/12\/21.","journal-title":"Nucleic acids research."},{"issue":"6","key":"9292_CR13","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/humu.22781","volume":"36","author":"BD Webb","year":"2015","unstructured":"Webb BD, Wheeler PG, Hagen JJ, Cohen N, Linderman MD, Diaz GA, et al. Novel, compound heterozygous, single-nucleotide variants in MARS2 associated with developmental delay, poor growth, and sensorineural hearing loss. Hum Mutat. 2015;36(6):587\u201392 Epub 2015\/03\/11.","journal-title":"Hum Mutat."},{"issue":"3","key":"9292_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001288","volume":"10","author":"V Bayat","year":"2012","unstructured":"Bayat V, Thiffault I, Jaiswal M, Tetreault M, Donti T, Sasarman F, et al. Mutations in the mitochondrial methionyl-tRNA synthetase cause a neurodegenerative phenotype in flies and a recessive ataxia (ARSAL) in humans. PLoS biology. 2012;10(3):e1001288 Epub 2012\/03\/27.","journal-title":"PLoS biology."},{"issue":"3","key":"9292_CR15","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1042\/BJ20110795","volume":"441","author":"L van Berge","year":"2012","unstructured":"van Berge L, Dooves S, van Berkel CG, Polder E, van der Knaap MS, Scheper GC. Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation is associated with cell-type-dependent splicing of mtAspRS mRNA. The Biochemical journal. 2012;441(3):955\u201362 Epub 2011\/10\/26.","journal-title":"The Biochemical journal."},{"key":"9292_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/8904_2015_434","volume":"23","author":"R Biancheri","year":"2015","unstructured":"Biancheri R, Lamantea E, Severino M, Diodato D, Pedemonte M, Cassandrini D, et al. Expanding the clinical and magnetic resonance spectrum of leukoencephalopathy with thalamus and brainstem involvement and high lactate (LTBL) in a Patient Harboring a Novel EARS2 Mutation. JIMD reports. 2015;23:85\u20139 Epub 2015\/04\/10.","journal-title":"JIMD reports."},{"issue":"4","key":"9292_CR17","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/j.1574-6976.2008.00119.x","volume":"32","author":"CD Hausmann","year":"2008","unstructured":"Hausmann CD, Ibba M. Aminoacyl-tRNA synthetase complexes: molecular multitasking revealed. FEMS microbiology reviews. 2008;32(4):705\u201321 Epub 2008\/06\/05.","journal-title":"FEMS microbiology reviews."},{"issue":"Pt 5","key":"9292_CR18","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1093\/brain\/aws070","volume":"135","author":"ME Steenweg","year":"2012","unstructured":"Steenweg ME, Ghezzi D, Haack T, Abbink TE, Martinelli D, van Berkel CG, et al. Leukoencephalopathy with thalamus and brainstem involvement and high lactate 'LTBL' caused by EARS2 mutations. Brain. 2012;135(Pt 5):1387\u201394 Epub 2012\/04\/12.","journal-title":"Brain"},{"issue":"11","key":"9292_CR19","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1177\/0883073810370897","volume":"25","author":"J Lin","year":"2010","unstructured":"Lin J, Chiconelli Faria E, Da Rocha AJ, Rodrigues Masruha M, Pereira Vilanova LC, Scheper GC, et al. Leukoencephalopathy with brainstem and spinal cord involvement and normal lactate: a new mutation in the DARS2 gene. J Child Neurol. 2010;25(11):1425\u20138 Epub 2010\/05\/27.","journal-title":"J Child Neurol."},{"key":"9292_CR20","volume-title":"Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation","author":"MS van der Knaap","year":"1993","unstructured":"van der Knaap MS, Salomons GS. Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, LJH B, Stephens K, et al., editors. . Seattle (WA): GeneReviews((R)); 1993."},{"key":"9292_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jns.2017.03.006","volume":"376","author":"J Finsterer","year":"2017","unstructured":"Finsterer J, Zarrouk-Mahjoub S. Phenotypic spectrum of DARS2 mutations. Journal of the neurological sciences. 2017;376:117\u20138 Epub 2017\/04\/23.","journal-title":"Journal of the neurological sciences."},{"issue":"Pt 4","key":"9292_CR22","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/brain\/awu026","volume":"137","author":"L van Berge","year":"2014","unstructured":"van Berge L, Hamilton EM, Linnankivi T, Uziel G, Steenweg ME, Isohanni P, et al. Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation: clinical and genetic characterization and target for therapy. Brain. 2014;137(Pt 4):1019\u201329 Epub 2014\/02\/26.","journal-title":"Brain"},{"issue":"1","key":"9292_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1136\/jmg.2009.068221","volume":"47","author":"P Isohanni","year":"2010","unstructured":"Isohanni P, Linnankivi T, Buzkova J, Lonnqvist T, Pihko H, Valanne L, et al. DARS2 mutations in mitochondrial leucoencephalopathy and multiple sclerosis. Journal of medical genetics. 2010;47(1):66\u201370 Epub 2009\/07\/14.","journal-title":"Journal of medical genetics."},{"key":"9292_CR24","doi-asserted-by":"publisher","first-page":"17051","DOI":"10.1038\/hgv.2017.51","volume":"4","author":"K Shimojima","year":"2017","unstructured":"Shimojima K, Higashiguchi T, Kishimoto K, Miyatake S, Miyake N, Takanashi JI, et al. A novel DARS2 mutation in a Japanese patient with leukoencephalopathy with brainstem and spinal cord involvement but no lactate elevation. Hum Genome Variation. 2017;4:17051 Epub 2017\/11\/16.","journal-title":"Hum Genome Variation."},{"key":"9292_CR25","doi-asserted-by":"crossref","unstructured":"Yelam A, Nagarajan E, Chuquilin M, Govindarajan R. Leucoencephalopathy with brain stem and spinal cord involvement and lactate elevation: a novel mutation in the DARS2 gene. BMJ case reports. 2019;12(1). Epub 2019\/01\/13.","DOI":"10.1136\/bcr-2018-227755"},{"issue":"5","key":"9292_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.mcp.2015.06.005","volume":"29","author":"C Kohler","year":"2015","unstructured":"Kohler C, Heyer C, Hoffjan S, Stemmler S, Lucke T, Thiels C, et al. Early-onset leukoencephalopathy due to a homozygous missense mutation in the DARS2 gene. Molecular and cellular probes. 2015;29(5):319\u201322 Epub 2015\/09\/04.","journal-title":"Molecular and cellular probes."},{"issue":"4","key":"9292_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.braindev.2012.05.007","volume":"35","author":"S Yamashita","year":"2013","unstructured":"Yamashita S, Miyake N, Matsumoto N, Osaka H, Iai M, Aida N, et al. Neuropathology of leukoencephalopathy with brainstem and spinal cord involvement and high lactate caused by a homozygous mutation of DARS2. Brain Dev. 2013;35(4):312\u20136 Epub 2012\/06\/09.","journal-title":"Brain Dev."},{"issue":"3","key":"9292_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1399-0004.2011.01644.x","volume":"80","author":"N Miyake","year":"2011","unstructured":"Miyake N, Yamashita S, Kurosawa K, Miyatake S, Tsurusaki Y, Doi H, et al. A novel homozygous mutation of DARS2 may cause a severe LBSL variant. Clinical genetics. 2011;80(3):293\u20136 Epub 2011\/08\/06.","journal-title":"Clinical genetics."},{"issue":"2","key":"9292_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1042\/BJ20121564","volume":"450","author":"L van Berge","year":"2013","unstructured":"van Berge L, Kevenaar J, Polder E, Gaudry A, Florentz C, Sissler M, et al. Pathogenic mutations causing LBSL affect mitochondrial aspartyl-tRNA synthetase in diverse ways. Biochem J. 2013;450(2):345\u201350 Epub 2012\/12\/12.","journal-title":"Biochem J."},{"issue":"21","key":"9292_CR30","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1093\/hmg\/ddx307","volume":"26","author":"M Aradjanski","year":"2017","unstructured":"Aradjanski M, Dogan SA, Lotter S, Wang S, Hermans S, Wibom R, et al. DARS2 protects against neuroinflammation and apoptotic neuronal loss, but is dispensable for myelin producing cells. Human molecular genetics. 2017;26(21):4181\u20139 Epub 2017\/10\/07.","journal-title":"Human molecular genetics."},{"issue":"6","key":"9292_CR31","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1001\/archneurol.2011.1048","volume":"69","author":"ME Steenweg","year":"2012","unstructured":"Steenweg ME, Vanderver A, Ceulemans B, Prabhakar P, Regal L, Fattal-Valevski A, et al. Novel infantile-onset leukoencephalopathy with high lactate level and slow improvement. Archives of neurology. 2012;69(6):718\u201322 Epub 2012\/02\/09.","journal-title":"Archives of neurology."},{"issue":"1","key":"9292_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ejrad.2013.09.023","volume":"83","author":"H Kassem","year":"2014","unstructured":"Kassem H, Wafaie A, Abdelfattah S, Farid T. Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL): assessment of the involved white matter tracts by MRI. Eur J Radiol. 2014;83(1):191\u20136 Epub 2014\/02\/22.","journal-title":"Eur J Radiol."},{"issue":"6","key":"9292_CR33","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1055\/s-0032-1329395","volume":"43","author":"ME Steenweg","year":"2012","unstructured":"Steenweg ME, van Berge L, van Berkel CG, de Coo IF, Temple IK, Brockmann K, et al. Early-onset LBSL: how severe does it get? Neuropediatrics. 2012;43(6):332\u20138 Epub 2012\/10\/16.","journal-title":"Neuropediatrics."},{"issue":"Pt 11","key":"9292_CR34","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1093\/brain\/awr254","volume":"134","author":"ME Steenweg","year":"2011","unstructured":"Steenweg ME, Pouwels PJ, Wolf NI, van Wieringen WN, Barkhof F, van der Knaap MS. Leucoencephalopathy with brainstem and spinal cord involvement and high lactate: quantitative magnetic resonance imaging. Brain : a journal of neurology. 2011;134(Pt 11):3333\u201341 Epub 2011\/10\/19.","journal-title":"Brain : a journal of neurology."},{"issue":"2","key":"9292_CR35","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s00415-011-6176-9","volume":"259","author":"C Tzoulis","year":"2012","unstructured":"Tzoulis C, Tran GT, Gjerde IO, Aasly J, Neckelmann G, Rydland J, et al. Leukoencephalopathy with brainstem and spinal cord involvement caused by a novel mutation in the DARS2 gene. J Neurol. 2012;259(2):292\u20136 Epub 2011\/07\/28.","journal-title":"J Neurol."},{"issue":"2","key":"9292_CR36","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/ana.10456","volume":"53","author":"MS van der Knaap","year":"2003","unstructured":"van der Knaap MS, van der Voorn P, Barkhof F, Van Coster R, Krageloh-Mann I, Feigenbaum A, et al. A new leukoencephalopathy with brainstem and spinal cord involvement and high lactate. Annals of neurology. 2003;53(2):252\u20138 Epub 2003\/01\/31.","journal-title":"Annals of neurology."},{"issue":"4","key":"9292_CR37","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1212\/01.WNL.0000134658.35601.41","volume":"63","author":"T Linnankivi","year":"2004","unstructured":"Linnankivi T, Lundbom N, Autti T, Hakkinen AM, Koillinen H, Kuusi T, et al. Five new cases of a recently described leukoencephalopathy with high brain lactate. Neurology. 2004;63(4):688\u201392 Epub 2004\/08\/25.","journal-title":"Neurology."},{"issue":"2B","key":"9292_CR38","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1590\/S0004-282X2007000300028","volume":"65","author":"DG Tavora","year":"2007","unstructured":"Tavora DG, Nakayama M, Gama RL, Alvim TC, Portugal D, Comerlato EA. Leukoencephalopathy with brainstem and spinal cord involvement and high brain lactate: report of three Brazilian patients. Arquivos de neuro-psiquiatria. 2007;65(2B):506\u201311 Epub 2007\/08\/01.","journal-title":"Arquivos de neuro-psiquiatria."},{"issue":"9","key":"9292_CR39","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/acn3.232","volume":"2","author":"JM Tillema","year":"2015","unstructured":"Tillema JM, Derks MG, Pouwels PJ, de Graaf P, van Rappard DF, Barkhof F, et al. Volumetric MRI data correlate to disease severity in metachromatic leukodystrophy. Annals of clinical and translational neurology. 2015;2(9):932\u201340 Epub 2015\/09\/25.","journal-title":"Annals of clinical and translational neurology."},{"issue":"3","key":"9292_CR40","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1212\/01.WNL.0000079050.91337.83","volume":"61","author":"DJ Loes","year":"2003","unstructured":"Loes DJ, Fatemi A, Melhem ER, Gupte N, Bezman L, Moser HW, et al. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology. 2003;61(3):369\u201374 Epub 2003\/08\/13.","journal-title":"Neurology."},{"issue":"1","key":"9292_CR41","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12883-018-1180-7","volume":"18","author":"A Yahia","year":"2018","unstructured":"Yahia A, Elsayed L, Babai A, Salih MA, El-Sadig SM, Amin M, et al. Intra-familial phenotypic heterogeneity in a Sudanese family with DARS2-related leukoencephalopathy, brainstem and spinal cord involvement and lactate elevation: a case report. BMC neurology. 2018;18(1):175 Epub 2018\/10\/26.","journal-title":"BMC neurology."},{"issue":"2","key":"9292_CR42","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00415-010-5755-5","volume":"258","author":"P Labauge","year":"2011","unstructured":"Labauge P, Dorboz I, Eymard-Pierre E, Dereeper O, Boespflug-Tanguy O. Clinically asymptomatic adult patient with extensive LBSL MRI pattern and DARS2 mutations. Journal of neurology. 2011;258(2):335\u20137 Epub 2010\/09\/30.","journal-title":"Journal of neurology."},{"issue":"16","key":"9292_CR43","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1212\/WNL.0b013e31828cf846","volume":"80","author":"J Schicks","year":"2013","unstructured":"Schicks J, Schols L, van der Knaap MS, Synofzik M. Teaching NeuroImages: MRI guides genetics: leukoencephalopathy with brainstem and spinal cord involvement (LBSL). Neurology. 2013;80(16):e176\u20137 Epub 2013\/04\/17.","journal-title":"Neurology."},{"issue":"5","key":"9292_CR44","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.seizure.2012.03.003","volume":"21","author":"J Finsterer","year":"2012","unstructured":"Finsterer J, Zarrouk MS. Epilepsy in mitochondrial disorders. Seizure. 2012;21(5):316\u201321 Epub 2012\/03\/31.","journal-title":"Seizure."},{"issue":"2","key":"9292_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.seizure.2012.11.005","volume":"22","author":"J Finsterer","year":"2013","unstructured":"Finsterer J, Mahjoub SZ. Presentation of adult mitochondrial epilepsy. Seizure. 2013;22(2):119\u201323 Epub 2012\/12\/04.","journal-title":"Seizure."},{"issue":"2","key":"9292_CR46","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4103\/0028-3886.111123","volume":"61","author":"FB Cheng","year":"2013","unstructured":"Cheng FB, Shen PP, Zhou HW, Meng HM, Yang Y, Feng JC. Adult-onset leukoencephalopathy with brain stem and spinal cord involvement in Chinese Han population: a case report and literature review. Neurology India. 2013;61(2):161\u20133 Epub 2013\/05\/07.","journal-title":"Neurology India."},{"issue":"8","key":"9292_CR47","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1007\/s00415-013-6940-0","volume":"260","author":"MH Martikainen","year":"2013","unstructured":"Martikainen MH, Ellfolk U, Majamaa K. Impaired information-processing speed and working memory in leukoencephalopathy with brainstem and spinal cord involvement and elevated lactate (LBSL) and DARS2 mutations: a report of three adult patients. Journal of neurology. 2013;260(8):2078\u201383 Epub 2013\/05\/09.","journal-title":"Journal of neurology."},{"issue":"1","key":"9292_CR48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/hmg\/ddm284","volume":"17","author":"T Novoyatleva","year":"2008","unstructured":"Novoyatleva T, Heinrich B, Tang Y, Benderska N, Butchbach ME, Lorson CL, et al. Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing. Human molecular genetics. 2008;17(1):52\u201370 Epub 2007\/10\/05.","journal-title":"Human molecular genetics."},{"issue":"10","key":"9292_CR49","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1001\/archderm.137.10.1357","volume":"137","author":"L Moed","year":"2001","unstructured":"Moed L, Shwayder TA, Chang MW. Cantharidin revisited: a blistering defense of an ancient medicine. Archives of dermatology. 2001;137(10):1357\u201360 Epub 2001\/10\/27.","journal-title":"Archives of dermatology."},{"issue":"24","key":"9292_CR50","doi-asserted-by":"publisher","first-page":"10977","DOI":"10.7314\/APJCP.2014.15.24.10977","volume":"15","author":"L Han","year":"2014","unstructured":"Han L, Sun YJ, Pan YF, Ding H, Chen X, Zhang X. Cantharidin combined with chemotherapy for Chinese patients with metastatic colorectal cancer. Asian Pacific journal of cancer prevention : APJCP. 2014;15(24):10977\u20139 Epub 2015\/01\/22.","journal-title":"Asian Pacific journal of cancer prevention : APJCP."},{"issue":"Pt 2","key":"9292_CR51","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws197","volume":"136","author":"B Talim","year":"2013","unstructured":"Talim B, Pyle A, Griffin H, Topaloglu H, Tokatli A, Keogh MJ, et al. Multisystem fatal infantile disease caused by a novel homozygous EARS2 mutation. Brain. 2013;136(Pt 2):e228 Epub 2012\/09\/26.","journal-title":"Brain"},{"issue":"1","key":"9292_CR52","first-page":"64","volume":"47","author":"SH Kevelam","year":"2016","unstructured":"Kevelam SH, Klouwer FC, Fock JM, Salomons GS, Bugiani M, van der Knaap MS. Absent thalami caused by a homozygous EARS2 mutation: expanding disease spectrum of LTBL. Neuropediatrics. 2016;47(1):64\u20137 Epub 2015\/12\/01.","journal-title":"Neuropediatrics."},{"issue":"9","key":"9292_CR53","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.braindev.2016.04.002","volume":"38","author":"O Gungor","year":"2016","unstructured":"Gungor O, Ozkaya AK, Sahin Y, Gungor G, Dilber C, Aydin K. A compound heterozygous EARS2 mutation associated with mild leukoencephalopathy with thalamus and brainstem involvement and high lactate (LTBL). Brain & development. 2016;38(9):857\u201361 Epub 2016\/04\/28.","journal-title":"Brain & development."},{"key":"9292_CR54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/8904_2016_581","volume":"33","author":"R Oliveira","year":"2017","unstructured":"Oliveira R, Sommerville EW, Thompson K, Nunes J, Pyle A, Grazina M, et al. Lethal neonatal LTBL associated with biallelic EARS2 variants: case report and review of the reported neuroradiological features. JIMD reports. 2017;33:61\u20138 Epub 2016\/08\/31.","journal-title":"JIMD reports."},{"issue":"3","key":"9292_CR55","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s11011-016-9793-2","volume":"31","author":"K Danhauser","year":"2016","unstructured":"Danhauser K, Haack TB, Alhaddad B, Melcher M, Seibt A, Strom TM, et al. EARS2 mutations cause fatal neonatal lactic acidosis, recurrent hypoglycemia and agenesis of corpus callosum. Metabolic brain disease. 2016;31(3):717\u201321 Epub 2016\/01\/19.","journal-title":"Metabolic brain disease."},{"issue":"2","key":"9292_CR56","first-page":"108","volume":"48","author":"EA Sellars","year":"2017","unstructured":"Sellars EA, Balmakund T, Bosanko K, Nichols BL, Kahler SG, Zarate YA. Severe metabolic acidosis and hepatopathy due to leukoencephalopathy with thalamus and brainstem involvement and high lactate. Neuropediatrics. 2017;48(2):108\u201310 Epub 2016\/11\/23.","journal-title":"Neuropediatrics."},{"issue":"23","key":"9292_CR57","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1212\/WNL.0000000000000497","volume":"82","author":"C Dallabona","year":"2014","unstructured":"Dallabona C, Diodato D, Kevelam SH, Haack TB, Wong LJ, Salomons GS, et al. Novel (ovario) leukodystrophy related to AARS2 mutations. Neurology. 2014;82(23):2063\u201371 Epub 2014\/05\/09.","journal-title":"Neurology."},{"issue":"10","key":"9292_CR58","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/jhg.2016.64","volume":"61","author":"M Hamatani","year":"2016","unstructured":"Hamatani M, Jingami N, Tsurusaki Y, Shimada S, Shimojima K, Asada-Utsugi M, et al. The first Japanese case of leukodystrophy with ovarian failure arising from novel compound heterozygous AARS2 mutations. Journal of human genetics. 2016;61(10):899\u2013902 Epub 2016\/10\/26.","journal-title":"Journal of human genetics."},{"issue":"2","key":"9292_CR59","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/jhg.2016.126","volume":"62","author":"L Szpisjak","year":"2017","unstructured":"Szpisjak L, Zsindely N, Engelhardt JI, Vecsei L, Kovacs GG, Klivenyi P. Novel AARS2 gene mutation producing leukodystrophy: a case report. J Hum Genet. 2017;62(2):329\u201333 Epub 2016\/10\/14.","journal-title":"J Hum Genet."},{"issue":"4","key":"9292_CR60","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/ane.12954","volume":"138","author":"I Taglia","year":"2018","unstructured":"Taglia I, Di Donato I, Bianchi S, Cerase A, Monti L, Marconi R, et al. AARS2-related ovarioleukodystrophy: clinical and neuroimaging features of three new cases. Acta neurologica Scandinavica. 2018;138(4):278\u201383 Epub 2018\/05\/12.","journal-title":"Acta neurologica Scandinavica."},{"issue":"2","key":"9292_CR61","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000135","volume":"3","author":"R Lakshmanan","year":"2017","unstructured":"Lakshmanan R, Adams ME, Lynch DS, Kinsella JA, Phadke R, Schott JM, et al. Redefining the phenotype of ALSP and AARS2 mutation-related leukodystrophy. Neurol Genet. 2017;3(2):e135 Epub 2017\/03\/01.","journal-title":"Neurol Genet."},{"issue":"7","key":"9292_CR62","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s10038-018-0446-7","volume":"63","author":"Q Dong","year":"2018","unstructured":"Dong Q, Long L, Chang YY, Lin YJ, Liu M, Lu ZQ. An adolescence-onset male leukoencephalopathy with remarkable cerebellar atrophy and novel compound heterozygous AARS2 gene mutations: a case report. J Hum Genet. 2018;63(7):841\u20136 Epub 2018\/04\/19.","journal-title":"J Hum Genet."},{"issue":"1","key":"9292_CR63","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/13816810.2017.1350723","volume":"39","author":"JH Peragallo","year":"2018","unstructured":"Peragallo JH, Keller S, van der Knaap MS, Soares BP, Shankar SP. Retinopathy and optic atrophy: expanding the phenotypic spectrum of pathogenic variants in the AARS2 gene. Ophthalmic genetics. 2018;39(1):99\u2013102 Epub 2017\/08\/19.","journal-title":"Ophthalmic genetics."},{"issue":"4","key":"9292_CR64","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41431-017-0058-2","volume":"26","author":"R Kamps","year":"2018","unstructured":"Kamps R, Szklarczyk R, Theunissen TE, Hellebrekers D, Sallevelt S, Boesten IB, et al. Genetic defects in mtDNA-encoded protein translation cause pediatric, mitochondrial cardiomyopathy with early-onset brain disease. Eur J Hum Genet. 2018;26(4):537\u201351 Epub 2018\/02\/15.","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"9292_CR65","first-page":"258","volume":"28","author":"EW Sommerville","year":"2019","unstructured":"Sommerville EW, Zhou XL, Olahova M, Jenkins J, Euro L, Konovalova S, et al. Instability of the mitochondrial alanyl-tRNA synthetase underlies fatal infantile-onset cardiomyopathy. Human molecular genetics. 2019;28(2):258\u201368 Epub 2018\/10\/05.","journal-title":"Human molecular genetics."},{"issue":"5","key":"9292_CR66","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1017\/S1047951116001876","volume":"27","author":"S Mazurova","year":"2017","unstructured":"Mazurova S, Magner M, Kucerova-Vidrova V, Vondrackova A, Stranecky V, Pristoupilova A, et al. Thymidine kinase 2 and alanyl-tRNA synthetase 2 deficiencies cause lethal mitochondrial cardiomyopathy: case reports and review of the literature. Cardiology in the young. 2017;27(5):936\u201344 Epub 2016\/11\/15.","journal-title":"Cardiology in the young."},{"issue":"5","key":"9292_CR67","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ajhg.2011.04.006","volume":"88","author":"A Gotz","year":"2011","unstructured":"Gotz A, Tyynismaa H, Euro L, Ellonen P, Hyotylainen T, Ojala T, et al. Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy. American journal of human genetics. 2011;88(5):635\u201342 Epub 2011\/05\/10.","journal-title":"American journal of human genetics."},{"issue":"1","key":"9292_CR68","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ymgme.2007.11.018","volume":"94","author":"RH Haas","year":"2008","unstructured":"Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darin N, et al. The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab. 2008;94(1):16\u201337 Epub 2008\/02\/05.","journal-title":"Mol Genet Metab."},{"key":"9292_CR69","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev.genom.9.081307.164204","volume":"9","author":"A Antonellis","year":"2008","unstructured":"Antonellis A, Green ED. The role of aminoacyl-tRNA synthetases in genetic diseases. Annu Rev Genomics Hum Genet. 2008;9:87\u2013107 Epub 2008\/09\/05.","journal-title":"Annu Rev Genomics Hum Genet."},{"issue":"1-2","key":"9292_CR70","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.vph.2009.11.009","volume":"52","author":"MV Brown","year":"2010","unstructured":"Brown MV, Reader JS, Tzima E. Mammalian aminoacyl-tRNA synthetases: cell signaling functions of the protein translation machinery. Vasc Pharmacol. 2010;52(1-2):21\u20136 Epub 2009\/12\/08.","journal-title":"Vasc Pharmacol."},{"issue":"12","key":"9292_CR71","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1021\/bi047527z","volume":"44","author":"L Bonnefond","year":"2005","unstructured":"Bonnefond L, Fender A, Rudinger-Thirion J, Giege R, Florentz C, Sissler M. Toward the full set of human mitochondrial aminoacyl-tRNA synthetases: characterization of AspRS and TyrRS. Biochemistry. 2005;44(12):4805\u201316 Epub 2005\/03\/23.","journal-title":"Biochemistry."},{"issue":"2","key":"9292_CR72","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.febslet.2009.11.064","volume":"584","author":"M Guo","year":"2010","unstructured":"Guo M, Schimmel P, Yang XL. Functional expansion of human tRNA synthetases achieved by structural inventions. FEBS letters. 2010;584(2):434\u201342 Epub 2009\/11\/26.","journal-title":"FEBS letters."},{"issue":"10","key":"9292_CR73","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrc3124","volume":"11","author":"S Kim","year":"2011","unstructured":"Kim S, You S, Hwang D. Aminoacyl-tRNA synthetases and tumorigenesis: more than housekeeping. Nature reviews Cancer. 2011;11(10):708\u201318 Epub 2011\/09\/24.","journal-title":"Nature reviews Cancer."},{"key":"9292_CR74","doi-asserted-by":"publisher","first-page":"12061","DOI":"10.1038\/ncomms12061","volume":"7","author":"M Wang","year":"2016","unstructured":"Wang M, Sips P, Khin E, Rotival M, Sun X, Ahmed R, et al. Wars2 is a determinant of angiogenesis. Nat Commun. 2016;7:12061 Epub 2016\/07\/09.","journal-title":"Nat Commun."},{"issue":"12","key":"9292_CR75","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1016\/j.celrep.2018.11.080","volume":"25","author":"T Agnew","year":"2018","unstructured":"Agnew T, Goldsworthy M, Aguilar C, Morgan A, Simon M, Hilton H, et al. A Wars2 mutant mouse model displays OXPHOS deficiencies and activation of tissue-specific stress response pathways. Cell Rep. 2018;25(12):3315\u201328 e6. Epub 2018\/12\/20.","journal-title":"Cell Rep."},{"issue":"3","key":"9292_CR76","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.cmet.2014.02.004","volume":"19","author":"SA Dogan","year":"2014","unstructured":"Dogan SA, Pujol C, Maiti P, Kukat A, Wang S, Hermans S, et al. Tissue-specific loss of DARS2 activates stress responses independently of respiratory chain deficiency in the heart. Cell metabolism. 2014;19(3):458\u201369 Epub 2014\/03\/13.","journal-title":"Cell metabolism."},{"key":"9292_CR77","volume-title":"Childhood ataxia with central nervous system hypomyelination\/Vanishing White Matter","author":"R Schiffmann","year":"1993","unstructured":"Schiffmann R, Fogli A, van der Knaap MS, Boespflug-Tanguy O. Childhood ataxia with central nervous system hypomyelination\/Vanishing White Matter. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, LJH B, Stephens K, et al., editors. . Seattle (WA): GeneReviews((R)); 1993."},{"issue":"4","key":"9292_CR78","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1212\/WNL.48.4.845","volume":"48","author":"MS van der Knaap","year":"1997","unstructured":"van der Knaap MS, Barth PG, Gabreels FJ, Franzoni E, Begeer JH, Stroink H, et al. A new leukoencephalopathy with vanishing white matter. Neurology. 1997;48(4):845\u201355 Epub 1997\/04\/01.","journal-title":"Neurology."},{"issue":"4","key":"9292_CR79","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/ng764","volume":"29","author":"PA Leegwater","year":"2001","unstructured":"Leegwater PA, Vermeulen G, Konst AA, Naidu S, Mulders J, Visser A, et al. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nature genetics. 2001;29(4):383\u20138 Epub 2001\/11\/13.","journal-title":"Nature genetics."},{"key":"9292_CR80","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12881-015-0204-z","volume":"16","author":"NC Wortham","year":"2015","unstructured":"Wortham NC, Proud CG. Biochemical effects of mutations in the gene encoding the alpha subunit of eukaryotic initiation factor (eIF) 2B associated with Vanishing White Matter disease. BMC Med Genet. 2015;16:64 Epub 2015\/08\/20.","journal-title":"BMC Med Genet."},{"issue":"11","key":"9292_CR81","doi-asserted-by":"publisher","first-page":"6603","DOI":"10.1128\/MCB.16.11.6603","volume":"16","author":"W Yang","year":"1996","unstructured":"Yang W, Hinnebusch AG. Identification of a regulatory subcomplex in the guanine nucleotide exchange factor eIF2B that mediates inhibition by phosphorylated eIF2. Molecular and cellular biology. 1996;16(11):6603\u201316 Epub 1996\/11\/01.","journal-title":"Molecular and cellular biology."},{"key":"9292_CR82","doi-asserted-by":"crossref","unstructured":"Hinnebusch AG, Lorsch JR. The mechanism of eukaryotic translation initiation: new insights and challenges. Cold Spring Harbor perspectives in biology. 2012;4(10). Epub 2012\/07\/21.","DOI":"10.1101\/cshperspect.a011544"},{"issue":"6238","key":"9292_CR83","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1126\/science.aaa6986","volume":"348","author":"Y Sekine","year":"2015","unstructured":"Sekine Y, Zyryanova A, Crespillo-Casado A, Fischer PM, Harding HP, Ron D. Stress responses. Mutations in a translation initiation factor identify the target of a memory-enhancing compound. Science. 2015;348(6238):1027\u201330 Epub 2015\/04\/11.","journal-title":"Science."},{"key":"9292_CR84","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.07314","volume":"4","author":"C Sidrauski","year":"2015","unstructured":"Sidrauski C, Tsai JC, Kampmann M, Hearn BR, Vedantham P, Jaishankar P, et al. Pharmacological dimerization and activation of the exchange factor eIF2B antagonizes the integrated stress response. eLife. 2015;4:e07314 Epub 2015\/04\/16.","journal-title":"eLife."},{"issue":"3","key":"9292_CR85","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.nbd.2005.08.009","volume":"21","author":"B van Kollenburg","year":"2006","unstructured":"van Kollenburg B, Thomas AA, Vermeulen G, Bertrand GA, van Berkel CG, Pronk JC, et al. Regulation of protein synthesis in lymphoblasts from vanishing white matter patients. Neurobiol Dis. 2006;21(3):496\u2013504 Epub 2005\/09\/28.","journal-title":"Neurobiol Dis."},{"issue":"9","key":"9292_CR86","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/humu.21535","volume":"32","author":"R Liu","year":"2011","unstructured":"Liu R, van der Lei HD, Wang X, Wortham NC, Tang H, van Berkel CG, et al. Severity of vanishing white matter disease does not correlate with deficits in eIF2B activity or the integrity of eIF2B complexes. Hum Mutat. 2011;32(9):1036\u201345 Epub 2011\/05\/12.","journal-title":"Hum Mutat."},{"issue":"7","key":"9292_CR87","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/sj.ejhg.5201189","volume":"12","author":"A Fogli","year":"2004","unstructured":"Fogli A, Schiffmann R, Hugendubler L, Combes P, Bertini E, Rodriguez D, et al. Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients. European journal of human genetics : EJHG. 2004;12(7):561\u20136 Epub 2004\/04\/01.","journal-title":"European journal of human genetics : EJHG."},{"issue":"8","key":"9292_CR88","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1128\/MCB.24.8.3295-3306.2004","volume":"24","author":"W Li","year":"2004","unstructured":"Li W, Wang X, Van Der Knaap MS, Proud CG. Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways. Mol Cell Biol. 2004;24(8):3295\u2013306 Epub 2004\/04\/03.","journal-title":"Mol Cell Biol."},{"key":"9292_CR89","doi-asserted-by":"crossref","unstructured":"Wong YL, LeBon L, Edalji R, Lim HB, Sun C, Sidrauski C. The small molecule ISRIB rescues the stability and activity of Vanishing White Matter Disease eIF2B mutant complexes. eLife. 2018;7 Epub 2018\/03\/01.","DOI":"10.7554\/eLife.32733"},{"issue":"10","key":"9292_CR90","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1097\/NEN.0b013e3181f2eafa","volume":"69","author":"M Bugiani","year":"2010","unstructured":"Bugiani M, Boor I, Powers JM, Scheper GC, van der Knaap MS. Leukoencephalopathy with vanishing white matter: a review. Journal of neuropathology and experimental neurology. 2010;69(10):987\u201396 Epub 2010\/09\/15.","journal-title":"Journal of neuropathology and experimental neurology."},{"issue":"4","key":"9292_CR91","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1172\/JCI83908","volume":"126","author":"S Dooves","year":"2016","unstructured":"Dooves S, Bugiani M, Postma NL, Polder E, Land N, Horan ST, et al. Astrocytes are central in the pathomechanisms of vanishing white matter. J Clin Investig. 2016;126(4):1512\u201324 Epub 2016\/03\/15.","journal-title":"J Clin Investig."},{"issue":"1","key":"9292_CR92","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/NEN.0b013e318203ae74","volume":"70","author":"M Bugiani","year":"2011","unstructured":"Bugiani M, Boor I, van Kollenburg B, Postma N, Polder E, van Berkel C, et al. Defective glial maturation in vanishing white matter disease. Journal of neuropathology and experimental neurology. 2011;70(1):69\u201382 Epub 2010\/12\/16.","journal-title":"Journal of neuropathology and experimental neurology."},{"key":"9292_CR93","doi-asserted-by":"crossref","unstructured":"Wong YL, LeBon L, Basso AM, Kohlhaas KL, Nikkel AL, Robb HM, et al. eIF2B activator prevents neurological defects caused by a chronic integrated stress response. eLife. 2019;8 Epub 2019\/01\/10.","DOI":"10.7554\/eLife.42940"}],"container-title":["Journal of Neurodevelopmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-019-9292-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s11689-019-9292-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-019-9292-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T00:11:12Z","timestamp":1607991072000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneurodevdisorders.biomedcentral.com\/articles\/10.1186\/s11689-019-9292-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["9292"],"URL":"https:\/\/doi.org\/10.1186\/s11689-019-9292-y","relation":{},"ISSN":["1866-1947","1866-1955"],"issn-type":[{"value":"1866-1947","type":"print"},{"value":"1866-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"18 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Regarding interests to declare, Dr. Fatemi is a paid drug safety monitoring board member for Bluebird Bio, Stealth Biotherapeutics, and paid consultant to Calico Labs. All other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}